Status:
UNKNOWN
HEMS for Mechanical Thrombectomy
Lead Sponsor:
Tampere University Hospital
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18-110 years
Brief Summary
Elapsed time from the onset of stroke symptoms to the point of revascularization is the key determinant of the optimal outcome of acute ischemic stroke. Pharmacological treatment is less effective if ...
Eligibility Criteria
Inclusion
- \- all adult patients transferred for mechanical thrombectomy from the South Ostrobothnia Hospital District to the Tampere University Hospital
Exclusion
- The neurologist on call at the Tampere University hospital deems the patient unable to benefit from mechanical thrombectomy
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04834284
Start Date
June 1 2020
End Date
December 31 2023
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tampere University hospital
Tampere, Finland, 33521